DFS
71
4
EQIX
55
2
C
44
3
CAH
64
3
AMZN
50
2
EMR
45
3
HBAN
70
5
DE
55
-5
AN
38
3
CFG
70
6
FIS
75
2
HD
50
3
AEP
75
-2
CNP
73
2
FFIV
61
4
DOV
59
2
ALL
67
-5
CSX
54
18
AMT
52
-4
CMA
52
3
DFS
71
4
EQIX
55
2
C
44
3
CAH
64
3
AMZN
50
2
EMR
45
3
HBAN
70
5
DE
55
-5
AN
38
3
CFG
70
6
FIS
75
2
HD
50
3
AEP
75
-2
CNP
73
2
FFIV
61
4
DOV
59
2
ALL
67
-5
CSX
54
18
AMT
52
-4
CMA
52
3
Financhill
Back

Soleno Therapeutics Stock Predictions

Meet the founder that's revolutionizing smartphones

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
82

SLNO
Soleno Therapeutics

Last Price:
$73.57
Seasonality Move:
2.33%

7 Day Trial

ALL ACCESS PASS

$ 7

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.

Soleno Therapeutics Stock Forecast

  • Over the next 52 weeks, Soleno Therapeutics has on average historically risen by 136.6% based on the past 10 years of stock performance.
  • Soleno Therapeutics has risen higher in 3 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 30%
  • Is Soleno Therapeutics Stock Undervalued?
    The current Soleno Therapeutics [SLNO] share price is $68.26. The Score for SLNO is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
  • SLNO is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.

Will Soleno Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Soleno Therapeutics has on average historically risen by 136.6% based on the past 10 years of stock performance.

Soleno Therapeutics Stock Rating

Buy
82
Soleno Therapeutics (SLNO) is a Buy

Is Soleno Therapeutics overpriced?

  • Soleno Therapeutics has risen higher in 3 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 30%

Soleno Therapeutics Stock Price History

Is SLNO stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SLNO is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
soleno.life

52-Week Data

52-Week High:
73.97
52-Week Low:
36.61

Prediction Charts

Market Cap:
3.1B
Price in USD:
68.26
Volume:
1.9M
Beta:
-0.34

Technical Analysis

SMA50:
49.82
SMA100:
49.79
SMA200:
49.12
52-Wk Change:
64.52%

Stock Predictions

  • Is Soleno Therapeutics stock public?
    Yes, Soleno Therapeutics is a publicly traded company.
  • What is the Soleno Therapeutics stock quote today?
    The Soleno Therapeutics stock price is 68.26 USD today.
  • How to buy Soleno Therapeutics stock online?
    You can buy Soleno Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-14 49.42 49.34 50.23 48.44
Mar-17 49.30 49.63 50.49 48.64
Mar-18 49.09 50.11 50.43 47.67
Mar-19 50.06 48.78 50.39 48.09
Mar-20 48.26 48.40 49.14 47.43
Mar-21 47.84 49.11 49.79 47.23
Mar-24 49.85 50.14 50.23 48.22
Mar-25 50.74 50.05 51.88 49.50
Mar-26 49.86 48.97 50.25 48.29
Mar-27 66.39 67.39 72.96 65.00
Mar-28 67.83 71.99 73.97 66.90
Mar-31 71.54 71.45 73.94 69.87
Apr-1 70.11 68.26 71.29 66.50
Apr-2 67.53 73.67 73.96 66.60

Soleno Therapeutics Earnings

Soleno Therapeutics Earnings Report: Per Share Soleno Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Soleno Therapeutics Forecast Revenue Growth

Soleno Therapeutics Stock Analysis: Historical quarterly revenues per share for Soleno Therapeutics and historical quarterly revenue growth:

* Soleno Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.